Project BioShield, the federal reserve fund created by Congress in 2004 to establish a $5.6 billion market for the development and production of drugs that could bioterror threats, has about $4.1 billion left to spend as of one year ago, according to a new report on the program prepared by the Department of Health and Human Services (HHS). So far, $1.9 billion remains to be spent from fiscal year 2004 through 2008 appropriations and another $2.2 billion is available between…
BioShield Still Has $4 Billion To Spend
SHARE:
